Fluidigm (FLDM) Tops Q4 EPS by 1c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results
February 10, 2020 4:05 PM ESTFourth quarter revenue of $32.4 million
Full year 2019 revenue increased 4 percent to $117.2 million; full year mass cytometry revenue increased 23 percent Landmark Nature publication demonstrates potential clinical value of using Imaging Mass Cytometry
Covance selects Fluidigm CyTOF technology to develop highly multiplexed human immune profiling services
SOUTH SAN FRANCISCO, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM) today announced financial results for the fourth quarter and full year ended December 31, 2019.
... More